Alltrna
PrivateLast Round
Series B
Aug 9, 2023
Total Funding Raised
$159M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Alltrna operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series B round in August 2023.
Alltrna is a biotechnology company that develops a tRNA-based therapeutic platform leveraging artificial intelligence and machine learning to advance programmable medicines for genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alltrna Comparables
Compare Alltrna with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tevard Biosciences | 88% | |
| Codone Biotechnology | 85% | |
| Shape Therapeutics | 83% |
For institutional investors. Book with your work email.
Alltrna Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 9, 2023 | ||||
| Seed | Nov 9, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Alltrna Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flagship Pioneering | Founding, Seed, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
Lead program AP003 is a tRNA oligonucleotide for Stop Codon Disease.
- Sep 3, 2025
David Hava appointed to lead tRNA medicines pipeline strategy.
For institutional investors. Book with your work email.
Alltrna Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alltrna's valuation, stock price, and market status.
Is Alltrna a public or private company?
Alltrna is a private company.
What is the current stock price of Alltrna?
Alltrna is a private company, so its shares have no public market price. Caplight tracks Alltrna's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alltrna worth (valuation)?
Valuation information for Alltrna is not publicly available.
Can I buy Alltrna stock?
Alltrna shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alltrna's last funding round?
Alltrna's most recent funding round was Series B on August 9, 2023.
Who are the main investors in Alltrna?
Key investors in Alltrna include Flagship Pioneering.
Will Alltrna IPO soon?
No public IPO plans have been announced for Alltrna.
How can I track Alltrna secondary market activity?
Caplight tracks bids, offers, and trades in Alltrna's shares on secondary markets.